{"id":51422,"date":"2025-12-18T21:19:26","date_gmt":"2025-12-18T13:19:26","guid":{"rendered":"https:\/\/flcube.com\/?p=51422"},"modified":"2025-12-18T21:19:27","modified_gmt":"2025-12-18T13:19:27","slug":"sirnaomics-partners-on-42m-small-nucleic-acid-fund-in-hangzhou","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=51422","title":{"rendered":"Sirnaomics Partners on $42M Small Nucleic Acid Fund in Hangzhou"},"content":{"rendered":"\n

Xinyuan Zhenghe (Hangzhou) Private Equity Fund Management Co., Ltd.<\/strong>, Sirnaomics<\/strong>, and the Fuyang Economic and Technological Development Zone Management Committee<\/strong> signed a framework agreement to launch a RMB 300 million ($42\u202fmillion) Small Nucleic Acid Industry Fund<\/strong>. The fund will be registered in Fuyang, Hangzhou, and managed by Xinyuan Zhenghe to support the entire oligonucleotide industry chain<\/strong>.<\/p>\n\n\n\n

Fund Structure<\/h2>\n\n\n\n
Component<\/th>Details<\/th><\/tr><\/thead>
Fund Size<\/strong><\/td>RMB 300 million (\u2248\u202fUSD\u202f42\u202fmillion)<\/td><\/tr>
Location<\/strong><\/td>Fuyang, Hangzhou<\/td><\/tr>
Manager<\/strong><\/td>Xinyuan Zhenghe (Hangzhou) Private Equity Fund Management<\/td><\/tr>
Key Partners<\/strong><\/td>Fuyang Economic & Technological Development Zone, Sirnaomics<\/td><\/tr>
Focus Area<\/strong><\/td>Small nucleic acid (oligonucleotide) industry chain<\/td><\/tr>
Registration<\/strong><\/td>December\u202f2025<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Investment Objectives<\/h2>\n\n\n\n
Objective<\/th>Scope<\/th><\/tr><\/thead>
Pipeline Support<\/strong><\/td>Accelerate development of Sirnaomics\u2019 core clinical pipelines<\/td><\/tr>
Broad Coverage<\/strong><\/td>Invest in small nucleic acid tech applications and innovative drugs for oncology and CNS<\/td><\/tr>
Technological Advancement<\/strong><\/td>Fund emerging nucleic acid technology projects<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Strategic Implications<\/h2>\n\n\n\n